Chembio Stock In The News

CEMI -  USA Stock  

USD 0.64  0.01  1.59%

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Chembio and other traded companies coverage. We help investors stay connected with Chembio headlines for the 24th of May to make an informed investment decision based on correlating the impacts of news items on Chembio Stock performance. Please note that trading solely based on the Chembio Diagnostics hype is not for everyone as timely availability and quick action are needed to avoid losses. The current Net Income Common Stock is estimated to decrease to about (34.8 M).
  
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Chembio Diagnostics headlines in addition to utilizing other, more conventional financial analysis modules. Continue to Chembio Diagnostics Backtesting and Chembio Diagnostics Hype Analysis.
Chembio Diagnostics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Chembio Diagnostics investors visualize upcoming and past events in order to time the market based on Chembio Diagnostics noise-free hype analysis.
Chembio Diagnostics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Chembio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Chembio Diagnostics that is available to investors today. That information is available publicly through Chembio media outlets and privately through word of mouth or via Chembio internal channels. However, regardless of the origin, that massive amount of Chembio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chembio Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chembio Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chembio Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chembio Diagnostics alpha.

Chembio Largest EPS Surprises

Earnings surprises can significantly impact Chembio Diagnostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-11-06
2014-09-30-0.02-0.03-0.0150 
2014-05-08
2014-03-31-0.01-0.02-0.01100 
2013-11-07
2013-09-300.080.07-0.0112 
2013-08-08
2013-06-30-0.04-0.030.0125 
2013-03-07
2012-12-310.050.060.0120 
2012-08-09
2012-06-300.030.040.0133 
View All Earnings Estimates

Chembio Diagnostics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Chembio Diagnostics Stock. Current markets are slightly bearish. About 53% of major world exchanges and indexes are down. See today's market update for more information.
news
20th of May 2022
Chembio Diagnostics Coverage Initiated at StockNews.com - Defense World
at www.defenseworld.net 
news
5th of May 2022
EPS Reported
at EPS REPORTED 
news
27th of April 2022
Chembio Diagnostics exotic insider transaction detected
at Angelico Paul 
benzinga news
21st of April 2022
Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022 - Benzin...
at www.benzinga.com 
news
7th of April 2022
Financial Statements
at SEC 
news
5th of April 2022
HIV Self Test Kits Market Size, Growth And Forecast OraSure Technologies Inc., Atomo Diagn...
at www.businessmerseyside.co.uk 
news
31st of March 2022
EPS Estimate
at EPS ESTIMATE 
news
15th of March 2022
Acquisition by Bespalko David William of 41143 shares of Chembio Diagnostics subject to Ru...
at Bespalko David William 
news
3rd of March 2022
EPS Reported
at EPS REPORTED 

Chembio Diagnostics Investors Sentiment

The influence of Chembio Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chembio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Chembio Diagnostics Implied Volatility

    
  43.59  
Chembio Diagnostics' implied volatility exposes the market's sentiment of Chembio Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chembio Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chembio Diagnostics stock will not fluctuate a lot when Chembio Diagnostics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.

Current Sentiment - CEMI

Chembio Diagnostics Investor Sentiment

Most of Macroaxis users are currently bullish on Chembio Diagnostics. What is your opinion about investing in Chembio Diagnostics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Chembio Diagnostics Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Chembio Diagnostics Backtesting and Chembio Diagnostics Hype Analysis. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.